“To Study The Association Of Leptin As A Predictive Marker In Obese And Non-Obese Women With Polycystic Ovary Syndrome Patients.”. (2022). Journal of Pharmaceutical Negative Results, 3930-3940. https://doi.org/10.47750/pnr.2022.13.S08.495 (Original work published 2022)